Medical professionals in Coimbatore advocate for increased HPV vaccine uptake to prevent cervical and other HPV-related ...

Two new observational studies highlight the outsized burden of cancer associated with human papillomavirus (HPV) among both ...

Women aged 65 and above are still at heightened risk of cervical cancer caused by human papillomavirus (HPV), suggest the findings of a large observational study published in the open access journal ...

SOLUTION Group Bhd (SGB), through its wholly-owned subsidiary Solution Biologics Sdn Bhd (SOLBIO), has signed an exclusive ...

Biological E partners with China’s Recbio to produce REC603 a 9-valent HPV vaccine in India The collaboration aims to expand ...

Low screening coverage, late diagnoses, high HIV prevalence, and limited access to treatment and vaccines are driving cervical cancer cases and deaths in South Africa. The country has a cervical ...

Jiangsu Recbio Technology and Biological E. Limited are partnering for HPV9 vaccine. Recbio will transfer technology to ...

According to the agreement, BE will receive the exclusive right to commercialise the vaccine in India and participate in ...

The implementation of these three key pillars — vaccination, screening, and treatment — are critical in eliminating cervical ...

Your premium access has ended, but the best of Nation.Africa is still within reach. Renew now to unlock exclusive stories and ...

A growing number of oncologists across India have expressed concern over Human Papillomavirus (HPV) becoming a major ...